In most cases, RACK1 has been reported to promote proliferation, radiation and chemotherapy resistance, invasion and metastasis in a variety of cancers, such as lung, liver, breast, esophageal, melanoma, glioma, myeloma and neuroblastoma [17–29]. Here, RACK1 is linked to cancer.